|Bid||93.64 x 1000|
|Ask||100.00 x 1100|
|Day's Range||97.96 - 99.58|
|52 Week Range||22.01 - 101.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Joining me today from ShockWave Medical are Doug Godshall, president and chief executive officer; Keith Dawkins, chief medical officer; and Dan Puckett, chief financial officer. Earlier today, ShockWave released financial results for the quarter ended September 30, 2020.
Shockwave Medical (SWAV) delivered earnings and revenue surprises of 30.91% and 34.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of ShockWave Medical (NASDAQ:SWAV) were flat in after-market trading after the company reported Q3 results.Quarterly Results Earnings per share were up 17.39% year over year to ($0.38), which beat the estimate of ($0.55).Revenue of $19,590,000 higher by 72.86% from the same period last year, which beat the estimate of $14,690,000.Looking Ahead Earnings guidance hasn't been issued by the company for now.ShockWave Medical hasn't issued any revenue guidance for the time being.Conference Call Details Date: Nov 09, 2020View more earnings on SWAVTime: 04:30 PMET Webcast URL: https://ir.shockwavemedical.com/events/event-details/shockwave-medical-inc-q3-2020-earnings-conference-callRecent Stock Performance Company's 52-week high was at $79.7452-week low: $22.01Price action over last quarter: Up 56.79%Company Profile ShockWave Medical Inc a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States.See more from Benzinga * Click here for options trades from Benzinga * Stocks That Hit 52-Week Highs On Monday * Earnings Scheduled For November 9, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.